Works matching AU Msaouel, Pavlos

Results: 79
    1
    2
    3
    4
    5
    6
    7

    Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. e16, doi. 10.1016/j.clgc.2021.07.004
    By:
    • Alhalabi, Omar;
    • Hahn, Andrew W.;
    • Msaouel, Pavlos;
    • Meric-Bernstam, Funda;
    • Wilson, Nathaniel;
    • Aung Naing;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Pant, Shubham;
    • Yap, Timothy A.;
    • Hong, David S.;
    • Siqing Fu;
    • Karp, Daniel;
    • Beltran, Kimberly;
    • Campbell, Erick;
    • Hung Le;
    • Campbell, Matthew T.;
    • Shah, Amishi;
    • Tannir, Nizar M.;
    • Siefker-Radtke, Arlene
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 9, p. e2122998, doi. 10.1001/jamanetworkopen.2021.22998
    By:
    • Msaouel, Pavlos;
    • Oromendia, Clara;
    • Siefker-Radtke, Arlene O.;
    • Tannir, Nizar M.;
    • Subudhi, Sumit K.;
    • Gao, Jianjun;
    • Wang, Yinghong;
    • Siddiqui, Bilal A.;
    • Shah, Amishi Y.;
    • Aparicio, Ana M.;
    • Campbell, Matthew T.;
    • Zurita, Amado J.;
    • Shaw, Leah K.;
    • Lopez, Lidia P.;
    • McCord, Heather;
    • Chakraborty, Sandip N.;
    • Perales, Jacqueline;
    • Lu, Cong;
    • Van Alstine, Michael L.;
    • Elashoff, Michael
    Publication type:
    Article
    15
    16
    17
    18
    19

    Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 6, p. 990, doi. 10.1093/jnci/djae028
    By:
    • Hsu, Eric J;
    • Lin, Timothy A;
    • Dabush, Dor R;
    • McCaw, Zachary;
    • Koong, Alex;
    • Lin, Christine;
    • Jaoude, Joseph Abi;
    • Patel, Roshal;
    • Kouzy, Ramez;
    • Alam, Molly B El;
    • Noticewala, Sonal;
    • Yang, Yumeng;
    • Sherry, Alexander D;
    • Fuller, Clifton D;
    • Thomas, Charles R;
    • Tang, Chad;
    • Msaouel, Pavlos;
    • Das, Prajnan;
    • Huang, Bo;
    • Tian, Lu
    Publication type:
    Article
    20

    Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.

    Published in:
    BJU International, 2022, v. 129, n. 5, p. 610, doi. 10.1111/bju.15541
    By:
    • De, Brian;
    • Venkatesan, Aradhana M.;
    • Msaouel, Pavlos;
    • Ghia, Amol J.;
    • Li, Jing;
    • Yeboa, Debra N.;
    • Nguyen, Quynh‐Nhu;
    • Bishop, Andrew J.;
    • Jonasch, Eric;
    • Shah, Amishi Y.;
    • Campbell, Matthew T.;
    • Wang, Jennifer;
    • Zurita‐Saavedra, Amado J.;
    • Karam, Jose A.;
    • Wood, Christopher G.;
    • Matin, Surena F.;
    • Tannir, Nizar M.;
    • Tang, Chad
    Publication type:
    Article
    21

    Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38342-7
    By:
    • Karam, Jose A.;
    • Msaouel, Pavlos;
    • Haymaker, Cara L.;
    • Matin, Surena F.;
    • Campbell, Matthew T.;
    • Zurita, Amado J.;
    • Shah, Amishi Y.;
    • Wistuba, Ignacio I.;
    • Marmonti, Enrica;
    • Duose, Dzifa Y.;
    • Parra, Edwin R.;
    • Soto, Luisa Maren Solis;
    • Laberiano-Fernandez, Caddie;
    • Lozano, Marisa;
    • Abraham, Alice;
    • Hallin, Max;
    • Chin, Curtis D.;
    • Olson, Peter;
    • Der-Torossian, Hirak;
    • Yan, Xiaohong
    Publication type:
    Article
    22

    A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 641, p. 1, doi. 10.1126/scitranslmed.abm6420
    By:
    • Msaouel, Pavlos;
    • Goswami, Sangeeta;
    • Thall, Peter F.;
    • Wang, Xuemei;
    • Yuan, Ying;
    • Jonasch, Eric;
    • Gao, Jianjun;
    • Campbell, Matthew T.;
    • Shah, Amishi Yogesh;
    • Corn, Paul Gettys;
    • Tam, Alda L.;
    • Ahrar, Kamran;
    • Rao, Priya;
    • Sircar, Kanishka;
    • Cohen, Lorenzo;
    • Basu, Sreyashi;
    • Duan, Fei;
    • Jindal, Sonali;
    • Zhang, Yuwei;
    • Chen, Hong
    Publication type:
    Article
    23

    2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.

    Published in:
    Canadian Urological Association Journal, 2024, v. 18, n. 11, p. E371, doi. 10.5489/cuaj.9041
    By:
    • Graham, Jeffrey;
    • Ahmad, Ardalan E.;
    • Basappa, Naveen S.;
    • Bernhard, Jean-Christophe;
    • Bhindi, Bimal;
    • Bossé, Dominick;
    • Breau, Rodney H.;
    • Canil, Christina M.;
    • Castonguay, Vincent;
    • Finelli, Antonio;
    • Heng, Daniel Y.C.;
    • Inman, Brant A.;
    • Kollmannsberger, Christian;
    • Lalani, Aly-Khan A.;
    • Lavallée, Luke T.;
    • Msaouel, Pavlos;
    • Prendeville, Susan;
    • Soleimani, Maryam;
    • Tanguay, Simon;
    • Wood, Lori
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.

    Published in:
    Oncologist, 2024, v. 29, n. 5, p. 392, doi. 10.1093/oncolo/oyad302
    By:
    • Hahn, Andrew W;
    • Surasi, Devaki Shilpa;
    • Viscuse, Paul V;
    • Bathala, Tharakeswara K;
    • Wiele, Andrew J;
    • Campbell, Matthew T;
    • Zurita, Amado J;
    • Shah, Amishi Y;
    • Jonasch, Eric;
    • Gao, Jianjun;
    • Goswami, Sangeeta;
    • Alhalabi, Omar;
    • Rao, Priya;
    • Sircar, Kanishka;
    • Tannir, Nizar M;
    • Msaouel, Pavlos
    Publication type:
    Article
    49
    50

    Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

    Published in:
    Oncologist, 2022, v. 27, n. 12, p. 1041, doi. 10.1093/oncolo/oyac158
    By:
    • Thouvenin, Jonathan;
    • Alhalabi, Omar;
    • Carlo, Maria;
    • Carril-Ajuria, Lucia;
    • Hirsch, Laure;
    • Martinez-Chanza, Nieves;
    • Négrier, Sylvie;
    • Campedel, Luca;
    • Martini, Dylan;
    • Borchiellini, Delphine;
    • Chahoud, Jad;
    • Lodi, Massimo;
    • Barthélémy, Philippe;
    • Hasanov, Elshad;
    • Hahn, Andrew W;
    • Gil, Thierry;
    • Viswanathan, Srinivas R;
    • Bakouny, Ziad;
    • Msaouel, Pavlos;
    • Bilen, Mehmet Asim
    Publication type:
    Article